Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LAM”

563 trials

Showing 20 of 563 results

Large-scale testing (Phase 3)UnknownNCT03236584
What this trial is testing

Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus Adefovir

Who this might be right for
Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48
Uijeongbu St. Mary Hospital 76
Not applicableStudy completedNCT01013272
What this trial is testing

Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load

Who this might be right for
Hepatitis B, Chronic
The University of Hong Kong 50
Not applicableUnknownNCT04600232
What this trial is testing

TB-LAM in the Diagnosis of TB

Who this might be right for
HIV InfectionsTuberculosisNon-Tuberculous Mycobacterial Pneumonia
Shanghai Public Health Clinical Center 400
Early research (Phase 1)Study completedNCT00326716
What this trial is testing

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Who this might be right for
HIV Infection
Bristol-Myers Squibb 69
Large-scale testing (Phase 3)Study completedNCT00424814
What this trial is testing

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 105
Testing effectiveness (Phase 2)Study completedNCT01541280
What this trial is testing

VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Nantes University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00000940
What this trial is testing

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 121
Large-scale testing (Phase 3)UnknownNCT04979468
What this trial is testing

Early DOlutegravir/LAmivudine Switching After Virological Suppression (EDOLAS Study)

Who this might be right for
HIV-1-infection
Societa' Italiana Di Malattie Infettive E Tropicali 440
Post-approval studies (Phase 4)UnknownNCT00426296
What this trial is testing

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Who this might be right for
HIV InfectionsLipodystrophy
Clinical Alliance for Research & Education - Infectious Diseases, LLC.
Large-scale testing (Phase 3)UnknownNCT04155554
What this trial is testing

Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based Regimen

Who this might be right for
HIV-1-infection
Azienda Ospedaliera Universitaria Senese 100
Not applicableStudy completedNCT04583904
What this trial is testing

Prospective Evaluation of Novel Diagnostics for Tuberculosis in KwaZulu-Natal, South Africa

Who this might be right for
Tuberculosis
University of Washington 843
Post-approval studies (Phase 4)Study completedNCT03033836
What this trial is testing

Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women

Who this might be right for
HIV Infections
Fundación Huésped 60
Testing effectiveness (Phase 2)Study completedNCT00000838
What this trial is testing

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 256
Testing effectiveness (Phase 2)Temporarily pausedNCT00004999
What this trial is testing

Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 350
Testing effectiveness (Phase 2)Study completedNCT02629822
What this trial is testing

Safety and Efficacy of Doravirine, Tenofovir, Lamivudine (MK-1439A) in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 10
Not applicableUnknownNCT05036694
What this trial is testing

Diagnostic Performance of a Novel Lipoarabinomannan.

Who this might be right for
HIV Primary Infection
Médecins Sans Frontières, Kenya 550
Testing effectiveness (Phase 2)Ended earlyNCT00104429
What this trial is testing

GW873140 In Combination With Combivir In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 125
Large-scale testing (Phase 3)Study completedNCT00023153
What this trial is testing

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

Who this might be right for
HIV InfectionsChronic Hepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 100
Post-approval studies (Phase 4)Study completedNCT00120354
What this trial is testing

Long-Term Lamivudine Therapy for Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Not applicableUnknownNCT03598556
What this trial is testing

Preventing Bone Loss Among Chinese Patients With HIV on ART

Who this might be right for
HIV/AIDSOsteoporosisBone Loss
Peking Union Medical College Hospital 600
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation